Rapidly evolving Creutzfeldt–Jakob disease in COVID-19: from early status epilepticus to fatal outcome.

Autor: Olivo, Sasha, Furlanis, Giovanni, Buoite Stella, Alex, Fabris, Martina, Milanic, Romina, Zanusso, Gianluigi, Manganotti, Paolo

Publikováno v: Acta Neurologica Belgica; Aug2023, Vol. 123 Issue 4, p1553-1556, 4p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Quality indicators for responsible antibiotic use in the inpatient setting: a systematic review followed by an international multidisciplinary consensus procedure

Autor: Monnier, Annelie A., Schouten, Jeroen, Le Marechal, Marion, Tebano, Gianpiero, Pulcini, Celine, Benic, Mirjana Stanic, Vlahovic-Palcevski, Vera, Milanic, Romina, Adriaenssens, Niels, Versporten, Ann, Huttner, Benedikt, Zanichelli, Veronica, Hulscher, Marlies E., Gyssens, Inge C.

Background: This study was conducted as part of the Driving Reinvestment in Research and Development and Responsible Antibiotic Use (DRIVE-AB) project and aimed to develop generic quality indicators (QIs) for responsible antibiotic use in the inpatie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______105::7d84156ab25756d3e849eb4ed00bde9f
http://hdl.handle.net/1942/27361

Antibiotic research and development: business as usual?

Autor: Harbarth, S., Theuretzbacher, U., Hackett, J., Adriaenssens, Niels, Anderson, James, Antonisse, Ad, Årdal, Christine, Baillon-Plot, Nathalie, Baraldi, Enrico, Bettiol, Esther, Bhatti, Taimur, Bradshaw, David, Brown, Nicholas, Carmeli, Yehuda, Cars, Otto, Charbonneau, Claudie, Cheng, Sue, Ciabuschi, Francesco, Cirino, Joseph, Clift, Charles, Colson, Abby, Dane, Aaron, De-Lima, Natalie, Dooa, Mindy, Drabik, Dusan, Eisenstein, Barry, Farquhar, Ronald, Fidan, Dogan, Findlay, David, Galli, Frederic, Gilchrist, Kim, Gilman, Steve, Goeschl, Timo, Goodall, Jonathan, Goossens, Herman, Gouglas, Dimitrios, Guise, Tracey, Gyssens, Inge, Hallerbäck, Peter, Heymann, David, Hoffman, Steven, Howell, Jenny, Hulscher, Marlies, Hunt, Timothy, Huttner, Benedikt, Jantarada, Fabricio, Jaquest, Dominique, Joly, Florence, Ka, Lum, Karas, Andreas, Knirsch, Charles, Kullberg, Bart-Jan, Laxminarayan, Ramanan, Le Maréchal, Marion, Legros, Stéphane, Lilliott, Nicky, Lindgren, Eva, Longshaw, Chris, Mahoney, Nicole, Mastrangelo, Dana, McDonald, John, McKeever, Steve, Mepham, Tim, Milanic, Romina, Monnier, Annelie, Morel, Chantal, Morton, Alec, Mossialos, Elias, Nolet, Brigitte, Outterson, Kevin, Payne, David, Piddock, Laura, Plahte, Jens, Potter, Danielle, Pulcini, Céline, Rex, John, Ross, Emma, Rottingen, John-Arne, Ryan, Kellie, Ryan, James, Salimi, Tehseen, Schouten, Jeroen, Schultz, Suzanne, So, Antony, Spiesser, Julie, Stålhammar, Nils-Olov, Stanic, Mirji, Tacconelli, Evelina, Temkin, Liz, Trick, Donald, Vink, Patrick, Vlahovic-Palcevski, Vera, Watt, Maureen, Wells, Marc, Wesseler, Justus, White, Alex, Wood, Susan, Zanichelli, Veronica, Zorzet, Anna

This article contends that poor economic incentives are an important reason for the lack of new drugs and explains how the DRIVE-AB intends to change the landscape by harnessing the expertise, motivation and diversity of its partners

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______805::947f636194a50408d094a58e8c89e765
http://doc.rero.ch/record/300479/files/dkv020.pdf